Accéder au contenu
Merck

Exercising Bioengineered Skeletal Muscle In Vitro: Biopsy to Bioreactor.

Methods in molecular biology (Clifton, N.J.) (2018-10-28)
Daniel C Turner, Andreas M Kasper, Robert A Seaborne, Alexander D Brown, Graeme L Close, Mark Murphy, Claire E Stewart, Neil R W Martin, Adam P Sharples
RÉSUMÉ

The bioengineering of skeletal muscle tissue in-vitro has enabled researchers to more closely mimic the in-vivo skeletal muscle niche. The three-dimensional (3-D) structure of the tissue engineered systems employed to date enable the generation of highly aligned and differentiated myofibers within a representative biological matrix. The use of electrical stimulation to model concentric contraction, via innervation of the myofibers, and the use of mechanical loading to model passive lengthening or stretch has begun to provide a manipulable environment to investigate the cellular and molecular responses following exercise mimicking stimuli in-vitro. Currently available bioreactor systems allow either electrical stimulation or mechanical loading to be utilized at any given time. In the present manuscript, we describe in detail the methodological procedures to create 3-D bioengineered skeletal muscle using both cell lines and/or primary human muscle derived cells from a tissue biopsy, through to modeling exercising stimuli using a bioreactor that can provide both electrical stimulation and mechanical loading simultaneously within the same in-vitro system.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-acide ascorbique, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
Fibrinogène from bovine plasma, Type I-S, 65-85% protein (≥75% of protein is clottable)
Sigma-Aldrich
Thrombine from bovine plasma, lyophilized powder, 40-300 NIH units/mg protein (biuret)
Sigma-Aldrich
Gelatin from porcine skin, gel strength 300, Type A
Sigma-Aldrich
Genipin, ≥98% (HPLC), powder
Sigma-Aldrich
6-Aminocaproic acid, BioUltra, ≥99%